DNPL has a proven track record of commercialising new molecules. Through our focus on research and development, we have developed expertise in APIs, intermediates, and botanical extracts, allowing us to anticipate and address unmet market needs in various therapeutic areas, including pharmaceutical, healthcare, life science, and more. Our dedication to quality is evident through our strict adherence to Good Manufacturing Practices (GMP), verified by regulatory bodies such as the US FDA, EU-GMP, and CDSCO.